Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Initial Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT02533700
What this trial is testing

CEOP/IVE/GDP Compared With CEOP as the First-line Therapy for Newly Diagnosed Adult Patients With PTCL

Who this might be right for
Peripheral T-Cell Lymphoma, Not Otherwise SpecifiedAngioimmunoblastic T Cell LymphomaALK-negative Anaplastic Large Cell Lymphoma+3 more
Shandong Provincial Hospital 106
Post-approval studies (Phase 4)UnknownNCT03017872
What this trial is testing

Dolutegravir and Darunavir Evaluation in Adults Failing Therapy

Who this might be right for
HIV Infections
Kirby Institute 831
Large-scale testing (Phase 3)Study completedNCT03150875
What this trial is testing

A Study Comparing the Efficacy and Safety Between IBI308 and Docetaxel in Patients With Advanced or Metastatic NSCLC

Who this might be right for
Non-small Cell Lung Cancer
Innovent Biologics (Suzhou) Co. Ltd. 290
Testing effectiveness (Phase 2)Study completedNCT01763307
What this trial is testing

Examine the Effect of Reconval K1 Cream to Prevent Skin Toxicity From EGFRI

Who this might be right for
Rash Due to Epidermal Growth Factor Receptor Inhibitors
Hadassah Medical Organization 18
Not applicableStudy completedNCT06749977
What this trial is testing

P11-4 and Fluoride Varnish for Remineralization of Post-orthodontic Lesions

Who this might be right for
White Spot Lesions
Medical University of Sofia 45
Testing effectiveness (Phase 2)Ended earlyNCT03919175
What this trial is testing

Umbralisib and Rituximab as Initial Therapy for Patients With Follicular Lymphoma and Marginal Zone Lymphoma

Who this might be right for
LymphomaFollicular LymphomaFollicular Lymphoma, Grade 1+4 more
Massachusetts General Hospital 18
Not applicableLooking for participantsNCT06657157
What this trial is testing

Peripheral Neuropathy in Patients Receiving Enfortumab Vedotin and Pembrolizumab as First Line Treatment for Metastatic or Locally Advanced Urothelial Carcinoma

Who this might be right for
Urothelial Cancer
Comprehensive Cancer Center Munich (CCCM) 80
Not applicableStudy completedNCT01777945
What this trial is testing

XEBRA Study: An Observational Study of Xeloda (Capecitabine) in Combination With Docetaxel in First Line in Participants With HER2-Negative Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 46
Testing effectiveness (Phase 2)Study completedNCT03374657
What this trial is testing

A First-in-human, Proof of Concept Study of CPK850 in Patients With RLBP1 Retinitis Pigmentosa

Who this might be right for
Retinitis Pigmentosa
Novartis Pharmaceuticals 12
Testing effectiveness (Phase 2)Study completedNCT00364611
What this trial is testing

Pilot Study of Docetaxel & Bevacizumab +/- Trastuzumab in First-Line Treatment of Patients With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Sanofi 73
Not applicableLooking for participantsNCT06991790
What this trial is testing

Sacituzumab Govitecan + Toripalimab as First - Line Therapy for Advanced Triple - Negative Breast Cancer and Biomarker Exploration

Who this might be right for
TNBC
Peking University Cancer Hospital & Institute 51
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07382713
What this trial is testing

Fluzoparib Plus Famitinib Maintenance After First-Line Platinum Response in Advanced Ovarian Cancer

Who this might be right for
Ovarian Cancer
Jinhua Zhou 43
Large-scale testing (Phase 3)Study completedNCT01232920
What this trial is testing

First-line Antimetabolites as Steroid-sparing Treatment Uveitis Pilot Trial

Who this might be right for
Uveitis
University of California, San Francisco 80
Not applicableLooking for participantsNCT04790682
What this trial is testing

LIquid Biopsy to prEdict Responses To First-line immunotherapY in Metastatic Non-small Cell LUNG Cancer. LIBERTY LUNG

Who this might be right for
Metastatic Lung Cancer
Institut Curie 300
Large-scale testing (Phase 3)WithdrawnNCT00403182
What this trial is testing

Chemotherapy and Hormone Therapy as First-Line Therapy in Treating Postmenopausal Women With Metastatic or Locally Advanced Breast Cancer

Who this might be right for
Breast Cancer
Technical University of Munich
Not applicableEnded earlyNCT02205645
What this trial is testing

Initial Safety Evaluation of FibroFix™ Meniscus

Who this might be right for
Other Tear of Medial Meniscus, Current Injury
Orthox Limited 4
Testing effectiveness (Phase 2)Ended earlyNCT04442581
What this trial is testing

Cabozantinib and Pembrolizumab for the First-Line Treatment of Advanced Liver Cancer

Who this might be right for
Advanced Hepatocellular CarcinomaBCLC Stage B Hepatocellular CarcinomaBCLC Stage C Hepatocellular Carcinoma
University of Washington 2
Large-scale testing (Phase 3)Study completedNCT00200681
What this trial is testing

IFM 2005-01: Velcade/Dexamethasone Versus Vincristine/Adriamycin (Doxorubicin)/Dexamethasone (VAD) for the Treatment of Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Nantes University Hospital 493
Large-scale testing (Phase 3)Study completedNCT01461928
What this trial is testing

A Study Comparing Maintenance Subcutaneous Rituximab With Observation Only in Participants With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma Who Had Responded to Rituximab-based Immunochemotherapy Induction and 2-year Maintenance With Subcutaneous Rituximab

Who this might be right for
Non-Hodgkin's Lymphoma
Hoffmann-La Roche 692
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07692334
What this trial is testing

Becotatugvedotin Plus Pucotenlimab in EGFR-Positive Advanced Gastric/GEJ Adenocarcinoma

Who this might be right for
Gastric CancerGastroesophageal Junction (GEJ) AdenocarcinomaBecotatug Vedotin+1 more
West China Second University Hospital 28
Next Page